The seed round was led by XTX Ventures and Prostate Cancer Research to support regulatory approvals and clinical studies.

Lucida Medical
Lucida Medical develops artificial intelligence software to assist radiologists in cancer screening.
£2.0MTotal raised
Lucida Medical develops software that uses artificial intelligence to help radiologists detect cancer more accurately from magnetic resonance imaging scans. The company focuses initially on prostate cancer, aiming to improve early diagnosis and reduce unnecessary biopsies.
Categories
Founders

Evis Sala
Chief Medical Officer
Evis co-founded Lucida Medical and served as its Chief Medical Officer. She has held academic and clinical roles at the University of Cambridge, Weill Cornell Medicine, and Università Cattolica del Sacro Cuore, alongside serving as Minister of Health and Social Protection in Albania.
LinkedInAR
Investors
Funding history
£2.0M